Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-[4-[(4-Fluorophenyl)methyl]phenyl]piperazine → 5-[2-(4-(4-(4-Fluorophenyl)methylphenyl)piperazin-1-yl)acetyl]-2,3,4,5-tetrahydro-1,5-benzoxazepine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-[4-[(4-Fluorophenyl)methyl]phenyl]piperazine | HCID 1519998 | — |
| 반응물 | 5-(2-Bromoacetyl)-2,3,4,5-tetrahydro-1,5-benzoxazepine | HCID 19694255 | — |
| 생성물 | 5-[2-(4-(4-(4-Fluorophenyl)methylphenyl)piperazin-1-yl)acetyl]-2,3,4,5-tetrahydro-1,5-benzoxazepine | HCID 19694252 | — |
반응 단계
The compound (15) synthesized in Reference Example and the compound (5) synthesized in Reference Example were used to produce the above compound in the same way as Example 1.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05723475 |
| 출처 데이터셋 | uspto-grants-1998_03 |
| ORD ID | ord-29980035cd8743d88cbb26a64e2988b5 |
| 출처 메모 | uspto-grants-1998_03 |